Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with Veeda Clinical Research Read more
Boehringer Ingelheim and Click Therapeutics join hands for CT-155, digital therapeutic for schizophrenia Read more
Immune Regulation and DynPort Vaccine Company partner to advance COVID-19 drug in clinical trials Read more